Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors. Dr. Davidson is currently CEO of New Amsterdam Pharma
Although there are evidence-based links between CVD and inflammatory conditions, and associated strong risk factors, they are often ignored when treating patients with either type of condition.
Aortic valve stenosis (a severe form of aortic valve disease) is the narrowing of the exit to the left ventricle of the heart. It is the most common form of valve disease, affecting more than one million patients in North America each year.
Foundation Recognized for its Efforts to Prevent Premature Cardiovascular Disease due to High Lipoprotein(a), Reaching more than 110,000 People per Year in more than 160 Countries
The high cost of health care is not a new discussion. Each day, we are inundated with heartbreaking stories of patients without access to essential therapies due to rising costs or the inability to pay momentous medical bills.
CardioVax, a privately held, clinical-stage biopharmaceutical company developing novel antibody therapeutics for inflammatory diseases, announced today that it has changed its name to Abcentra.
